Literature DB >> 18663823

Value in development of a TAPIR-like mouse monoclonal antibody to Abeta.

Kumar Sambamurti1, Miguel A Pappolla, K S Jagannatha Rao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18663823      PMCID： PMC2863094          DOI： 10.3233/jad-2008-14205

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


× No keyword cloud information.
  20 in total

Review 1.  Alzheimer's disease: genes, proteins, and therapy.

Authors:  D J Selkoe
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 2.  Metals and Alzheimer's disease.

Authors:  Paul A Adlard; Ashley I Bush
Journal:  J Alzheimers Dis       Date:  2006-11       Impact factor: 4.472

Review 3.  Clinical observations with AN-1792 using TAPIR analyses.

Authors:  Christoph Hock; Roger M Nitsch
Journal:  Neurodegener Dis       Date:  2005       Impact factor: 2.977

4.  A specific amyloid-beta protein assembly in the brain impairs memory.

Authors:  Sylvain Lesné; Ming Teng Koh; Linda Kotilinek; Rakez Kayed; Charles G Glabe; Austin Yang; Michela Gallagher; Karen H Ashe
Journal:  Nature       Date:  2006-03-16       Impact factor: 49.962

5.  Abeta species removal after abeta42 immunization.

Authors:  James A R Nicoll; Edward Barton; Delphine Boche; Jim W Neal; Isidro Ferrer; Petrina Thompson; Christina Vlachouli; David Wilkinson; Antony Bayer; Dora Games; Peter Seubert; Dale Schenk; Clive Holmes
Journal:  J Neuropathol Exp Neurol       Date:  2006-11       Impact factor: 3.685

6.  Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

Authors:  Eric Steen; Benjamin M Terry; Enrique J Rivera; Jennifer L Cannon; Thomas R Neely; Rose Tavares; X Julia Xu; Jack R Wands; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2005-02       Impact factor: 4.472

Review 7.  A partial failure of membrane protein turnover may cause Alzheimer's disease: a new hypothesis.

Authors:  Kumar Sambamurti; Anitha Suram; Chitra Venugopal; Annamalai Prakasam; Yan Zhou; Debomoy K Lahiri; Nigel H Greig
Journal:  Curr Alzheimer Res       Date:  2006-02       Impact factor: 3.498

8.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

Authors:  Irene H Cheng; Kimberly Scearce-Levie; Justin Legleiter; Jorge J Palop; Hilary Gerstein; Nga Bien-Ly; Jukka Puoliväli; Sylvain Lesné; Karen H Ashe; Paul J Muchowski; Lennart Mucke
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

9.  Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

Authors:  N C Fox; R S Black; S Gilman; M N Rossor; S G Griffith; L Jenkins; M Koller
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

Review 10.  Has the amyloid cascade hypothesis for Alzheimer's disease been proved?

Authors:  John Hardy
Journal:  Curr Alzheimer Res       Date:  2006-02       Impact factor: 3.498
View more
  1 in total

Review 1.  Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.

Authors:  Johant Lakey-Beitia; Ruben Berrocal; K S Rao; Armando A Durant
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.